Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort study
Date
2014
Authors
O'Carrigan, B.
Fournier, M.
Olver, I.
Stockler, M.
Whitford, H.
Toner, G.
Thomson, D.
Davis, I.
Hanning, F.
Singhal, N.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Internal Medicine Journal, 2014; 44(8):813-817
Statement of Responsibility
B. O'Carrigan, M. Fournier, I. N. Olver, M. R. Stockler, H. Whitford, G. C. Toner, D. B. Thomson, I. D. Davis, F. Hanning, N. Singhal, C. Underhill, P. Clingan, A. McDonald, A. Boland, P. Grimison and Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Conference Name
Abstract
This is the first prospective study in a contemporary Australian/New Zealand population to determine the prevalence of testosterone deficiency in testicular cancer survivors at 12 months from treatment, and any association with poorer quality of life. Hormone assays from 54 evaluable patients in a prospective cohort study revealed biochemical hypogonadism in 18 patients (33%) and low-normal testosterone in 13 patients (24%). We found no association between testosterone levels and quality of life (all P > 0.05). Hypogonadal patients should be considered for testosterone replacement to prevent long-term morbidity.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© 2014 The Authors; Internal Medicine Journal © 2014 Royal Australasian College of Physicians